Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Depreciation and Depletion: 2022-2024

Historic Depreciation and Depletion for Dianthus Therapeutics (DNTH) over the last 3 years, with Dec 2024 value amounting to $96,000.

  • Dianthus Therapeutics' Depreciation and Depletion rose 8.00% to $27,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $110,000, marking a year-over-year increase of 22.22%. This contributed to the annual value of $96,000 for FY2024, which is 43.28% up from last year.
  • As of FY2024, Dianthus Therapeutics' Depreciation and Depletion stood at $96,000, which was up 43.28% from $67,000 recorded in FY2023.
  • In the past 5 years, Dianthus Therapeutics' Depreciation and Depletion ranged from a high of $96,000 in FY2024 and a low of $30,000 during FY2022.
  • Its 3-year average for Depreciation and Depletion is $64,333, with a median of $67,000 in 2023.
  • Data for Dianthus Therapeutics' Depreciation and Depletion shows a peak YoY skyrocketed of 123.33% (in 2023) over the last 5 years.
  • Over the past 3 years, Dianthus Therapeutics' Depreciation and Depletion (Yearly) stood at $30,000 in 2022, then spiked by 123.33% to $67,000 in 2023, then skyrocketed by 43.28% to $96,000 in 2024.